AKLI
Akili Inc

828
Loading...
Loading...
News
all
press releases
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game
Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC (AKL-T01) as an over-the-counter treatment for...
Business Wire·1y ago
News Placeholder
More News
News Placeholder
AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLI
AKILI INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akili, Inc. - AKLI AKILI INVESTOR ALERT BY THE...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRO, ATRI, SRDX, AKLI on Behalf of Shareholders
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRO, ATRI, SRDX, AKLI on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MRO, ATRI, SRDX, AKLI on Behalf of...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate AKLI, WIRE, CBNK, IONM
SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate AKLI, WIRE, CBNK, IONM SHAREHOLDER UPDATE: Halper Sadeh LLC Continues to Investigate AKLI, WIRE, CBNK, IONM PR Newswire NEW YORK, June 4...
PR Newswire·1y ago
News Placeholder
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. - AKLI
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of the Merger and its Tender Offer, Expiring July 31, 2024, for Shares of Akili, Inc. - AKLI SHAREHOLDER INVESTIGATION...
PR Newswire·1y ago
News Placeholder
AKLI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akili, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Akili, Inc. (NASDAQ: AKLI) to Virtual Therapeutics for $0.4340 per share of common stock in cash is fair to Akili...
Business Wire·1y ago
News Placeholder
Shareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public Shareholders
Shareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair Price for its Public Shareholders Shareholder Alert: Ademi LLP investigates whether Akili, Inc. has obtained a Fair...
PR Newswire·1y ago
News Placeholder
Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement to Establish Leading Digital Health Company
Virtual Therapeutics, a company focused on improving mental health at scale using engaging, immersive games, and Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced...
Business Wire·1y ago
News Placeholder
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Akili, Inc. (Nasdaq: AKLI), a leading...
Business Wire·1y ago
News Placeholder
Akili Reports First Quarter 2024 Financial Results and Provides Business Update
Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today reported its financial results for the quarter ended March 31, 2024 and provided an update on business progress. As announced in...
Business Wire·1y ago

Latest AKLI News

View

Advertisement. Remove ads.

Advertisement. Remove ads.